tiprankstipranks
Trending News
More News >
Enovix (ENVX)
NASDAQ:ENVX
US Market

Enovix (ENVX) AI Stock Analysis

Compare
3,591 Followers

Top Page

ENVX

Enovix

(NASDAQ:ENVX)

Select Model
Select Model
Select Model
Neutral 52 (OpenAI - 5.2)
,
Neutral 52 (OpenAI - 5.2)
,
Neutral 52 (OpenAI - 5.2)
Rating:52Neutral
Price Target:
$5.00
▲(1.21% Upside)
Action:ReiteratedDate:02/26/26
The score is driven primarily by mixed fundamentals: strong revenue growth, improving margins, and a cleaner balance sheet are offset by very large ongoing losses and persistent cash burn. Technicals further weigh on the score as the stock remains in a clear downtrend. The earnings call adds support due to strong liquidity and improving commercialization indicators, but qualification and manufacturing execution risks remain significant.
Positive Factors
Strong liquidity & cleaner balance sheet
A large cash position and sharply reduced leverage (debt-to-equity ~0.08) provide multi-quarter runway to complete qualification, absorb scaling hiccups, and fund targeted CapEx without immediate external financing. This materially lowers balance-sheet risk and gives management flexibility for disciplined allocation and contingency actions over the next 2–6 months.
Improving revenue and gross margins
Sustained double-digit revenue growth from a small base plus meaningful margin improvement indicates improving unit economics as production scales and mix shifts to higher-margin defense products. If trends continue, higher margins can reduce incremental cash burn per dollar of revenue and improve path to operating leverage as volumes expand.
Multiple commercialization pathways & pipeline
Near-term smart-eyewear shipments and a sizable defense/drone pipeline diversify revenue sources beyond smartphones, shortening commercialization timelines and de-risking reliance on a single high-volume channel. These structural pathways improve probability of steady revenue growth while smartphone qualification proceeds.
Negative Factors
Large ongoing losses and negative cash flow
Despite revenue and margin gains, the company remains far from self-sustaining: substantial net losses and negative operating/free cash flow mean continued reliance on the cash runway or external funding. Over months, persistent burn could force delayed projects, slower capacity additions, or more dilutive financing if anticipated revenue ramps slip.
Smartphone qualification uncertainty
Smartphone OEM qualification is critical for large-scale volume but currently faces a material technical gap at accelerated cycle rates and ambiguous acceptance protocols. This creates structural timing risk: multi-path resolution options (waivers, protocol changes, reformulation) could push meaningful smartphone revenue into 2027, slowing scale economics and revenue diversification.
Manufacturing throughput constraint (Zone 1 dicing)
A production bottleneck in a core fab step limits the firm's ability to convert design wins into volume sales. Solving it may require process optimization or new technology and could trigger requalification demands from customers. This structural manufacturing risk affects achievable throughput, margin improvement cadence, and timing of capacity-driven revenue growth.

Enovix (ENVX) vs. SPDR S&P 500 ETF (SPY)

Enovix Business Overview & Revenue Model

Company DescriptionEnovix Corporation designs, develops, and manufactures lithium-ion batteries. The company was founded in 2007 and is headquartered in Fremont, California.
How the Company Makes MoneyEnovix makes money primarily by selling lithium-ion battery cells it manufactures using its proprietary silicon-anode battery architecture. Revenue is generated from (1) product sales of battery cells shipped to customers (recognized when control of the product transfers under customer contracts), and (2) related engineering, development, and qualification activities provided to customers as part of bringing cells into production (to the extent these are contracted and recognized as revenue). The company’s earnings potential is influenced by its ability to scale manufacturing capacity, achieve production yields and cost targets, and secure and expand customer adoption through design wins and multi-year supply arrangements. Specific material partnerships, customer names, pricing terms, and the split between product versus service/other revenue are null.

Enovix Earnings Call Summary

Earnings Call Date:Feb 25, 2026
(Q4-2025)
|
% Change Since: |
Next Earnings Date:May 06, 2026
Earnings Call Sentiment Positive
The call presented a number of meaningful operational and commercial positives: record quarterly and annual revenue, improved gross margins, a strong cash position ($621M), clear near-term commercialization pathways (smart eyewear shipments expected H2 2026), an expanding defense and drone pipeline (~$100M), and improving manufacturing yields and leadership. However, there are important near-term risks and uncertainties — most notably the smartphone qualification gap on the accelerated 0.7C cycle-life test, the Zone 1 dicing throughput constraint, continued substantial operating losses, and Q1 seasonality-driven revenue decline. Management articulated defined mitigation paths for technical and manufacturing challenges and emphasized ample liquidity and disciplined capital allocation. Overall, the progress and liquidity mitigate many risks, but timing and execution on qualification and scale remain key variables.
Q4-2025 Updates
Positive Updates
Record Quarterly and Annual Revenue
Q4 2025 revenue of $11.3M (record quarter), up 16% year-over-year; Full Year 2025 revenue of $31.8M (record year), up 38% year-over-year. Q4 revenue was above the top end of guidance ($10.5M).
Improving Gross Margins
Q4 non-GAAP gross profit of $2.9M for a non-GAAP gross margin of ~26%; Full Year 2025 non-GAAP gross margin improved to 23%, reflecting higher volumes and favorable mix shift toward higher-margin defense batteries after April 2025 asset acquisition.
Strong Liquidity and Capital Actions
Ended year with approximately $621M in cash, cash equivalents and marketable securities; Board authorized a share repurchase program, signaling balance-sheet strength and capital allocation flexibility.
Smartphone Qualification Progress
Engagement expanded to 7 of the top 8 global smartphone OEMs with formal qualification underway with lead mobile customer (Honor) since Q3 2025. Internal 0.2C cycle-life testing indicates likely exceedance of the 1,000-cycle requirement at 0.2C, increasing confidence toward smartphone integration and system planning.
Smart Eyewear — Near-Term Commercial Pathway
Smart eyewear positioned as an accelerated commercialization pathway due to lower qualification barriers and lower cycle-life thresholds; company preparing production to support initial high-volume demand from lead smart eyewear customer and expects first smart eyewear battery shipments in H2 2026. Company estimates smart-eyewear battery TAM could exceed $400M by 2030.
Defense and Drone Momentum / Pipeline
Defense shipments remained the largest contributor in 2025 (naval munitions top Q4 product); company reports a global pipeline of ~ $100M with multiple Tier 1 defense contractors. Drone battery opportunity highlighted with an estimated TAM of ~$1.5B this year.
Energy Density and R&D Roadmap
Internal testing shows a high-energy drone cell at ~342 Wh/kg with a roadmap targeting >400 Wh/kg for next-generation silicon-anode products, supporting longer flight times and expanded mission capabilities.
Operational and Manufacturing Strengthening
Key operational hires (Head of Global Manufacturing and Head of Advanced Manufacturing Engineering) added to support scale-up. Yields and throughput improving across Fab2; most process steps achieving >= ~80% yields and recent progress on rate-limiting Zone 1 laser dicing.
Negative Updates
Smartphone Accelerated Cycle-Life (0.7C) Shortfall
Batteries currently appear on track to exceed 1,000 cycles at 0.2C but are not on track to meet the accelerated 0.7C cycle-life requirement used by smartphone OEMs. Because no prior 100% silicon-anode smartphone battery qualification exists, test protocols are ambiguous, creating qualification risk and multiple possible (and time-consuming) resolution pathways.
Qualification Uncertainty and Potential Delay to Large-Scale Smartphone Commercialization
Three potential pathways (0.2C acceptance/waiver, new accelerated protocol, or electrochemistry reformulation to meet 0.7C) create timing uncertainty. Management expects possible volume in late 2026 or more likely 2027 for larger-scale smartphone commercialization depending on outcome.
Manufacturing Constraint — Zone 1 Laser Dicing
Zone 1 laser dicing identified as the primary rate-limiting factor for throughput. While progress is being made (yields close to 80% in Q4 and at ~80% quarter-to-date), this constraint requires process optimization or alternative dicing approaches to unlock higher production rates.
Ongoing Operating Losses and Cash Burn (Near-Term)
Non-GAAP loss from operations for Q4 was $28.9M (improved vs guidance but still sizable). Q1 2026 non-GAAP loss-from-operations guidance is $29M–$32M, indicating continuing substantial near-term operating losses while investing in qualification and manufacturing readiness.
Revenue Seasonality / Near-Term Guidance Shortfall vs Q4
Q1 2026 guidance of $6.5M–$7.5M implies a notable quarter-over-quarter decline from Q4's $11.3M, reflecting seasonality and defense program timing; revenue concentration in defense/industrial remains a near-term revenue mix dependency.
Capital Expenditure Timing and Payment Shifts
Timing of equipment and vendor payments caused actual cash payments in Q4 to be lower than previously guided, with the majority expected in H1 2026. Company expects Q1 CapEx of $9M–$11M and continues to phase broader capital decisions while scaling Fab2 and other lines.
Qualification/Requalification Risk from Process Changes
If the company changes dicing technology or other process steps to increase throughput, customers will require communication and potentially requalification or partial requalification, which could introduce delays or incremental testing.
Unclear Multiyear CapEx and Capacity Targets
Management did not provide multi-year CapEx or explicit megawatt-hour capacity targets; while Korea facility acquisition provides scalable footprint, lack of detailed long-term capital guidance introduces modeling uncertainty for capacity ramp timing and related revenue growth.
Company Guidance
Guidance for Q1 2026 called for revenue of $6.5 million to $7.5 million, non‑GAAP loss from operations of $29 million to $32 million, and capital expenditures of $9 million to $11 million (with the majority of Q4 equipment payments shifting into H1 2026); this follows a Q4 that beat top‑end revenue guidance ($11.3M versus $10.5M guide), produced $2.9M of non‑GAAP gross profit (~26% non‑GAAP gross margin), a non‑GAAP loss from operations of $28.9M (better than the $30–$33M guide) and non‑GAAP net loss per share of $0.14 (versus a $0.16–$0.20 guide); full‑year 2025 revenue was $31.8M (up 38% YoY) with full‑year non‑GAAP gross margin of 23%, ending the year with $621M in cash, cash equivalents and marketable securities, an authorized share repurchase program, a global defense pipeline of roughly $100M, and operational notes that yields are ≳80% (dicing ~80% to date) while drone cells are testing at ~342 Wh/kg with a roadmap targeting >400 Wh/kg.

Enovix Financial Statement Overview

Summary
Revenue is growing quickly and gross margin improved to ~19% in 2025, and leverage fell sharply (debt-to-equity ~0.08). However, losses remain very large (2025 net loss ~-$156.7M) and cash burn is still heavy (2025 operating cash flow ~-$95.3M; free cash flow ~-$113.5M), indicating the business is not yet near self-funding.
Income Statement
24
Negative
Revenue is growing from a small base (about $7.6M in 2023 to $31.8M in 2025), and gross margin improved materially (from deeply negative in 2023 to ~19% in 2025). However, profitability remains very weak: 2025 shows a large net loss (~-$156.7M) and deeply negative net margin (about -493%), indicating operating costs still vastly exceed the current revenue scale.
Balance Sheet
63
Positive
Leverage improved sharply by 2025, with debt-to-equity falling to ~0.08 (from ~0.78 in 2024), suggesting a much cleaner capital structure and lower balance-sheet risk. That said, returns remain poor with strongly negative return on equity in each year shown, reflecting ongoing losses that continue to erode economic value despite a sizable equity base.
Cash Flow
28
Negative
Cash generation is a key weak spot: operating cash flow is consistently negative (about -$95.3M in 2025) and free cash flow is also negative (about -$113.5M in 2025). While free cash burn improved versus 2024 (less negative), the company is still funding substantial outflows, and cash flow is not yet demonstrating self-sustaining operations.
BreakdownDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue31.82M23.07M7.64M6.20M0.00
Gross Profit6.11M-2.04M-55.42M-17.04M-1.97M
EBITDA-102.60M-172.18M-176.30M-189.34M-68.03M
Net Income-156.74M-222.24M-214.07M-51.62M-125.87M
Balance Sheet
Total Assets878.98M527.17M564.30M440.59M482.56M
Cash, Cash Equivalents and Short-Term Investments512.04M272.87M306.81M322.85M385.29M
Total Debt21.11M192.56M190.61M8.23M9.07M
Total Liabilities604.96M277.77M303.20M84.16M156.45M
Stockholders Equity271.21M246.74M258.15M356.43M326.12M
Cash Flow
Free Cash Flow-113.51M-184.82M-110.39M-118.95M-95.29M
Operating Cash Flow-95.29M-108.63M-104.64M-82.74M-51.70M
Investing Cash Flow-538.27M-1.38M-142.96M-36.21M-43.58M
Financing Cash Flow467.38M150.75M159.59M56.51M451.49M

Enovix Technical Analysis

Technical Analysis Sentiment
Negative
Last Price4.94
Price Trends
50DMA
6.52
Negative
100DMA
7.74
Negative
200DMA
9.31
Negative
Market Momentum
MACD
-0.44
Negative
RSI
37.77
Neutral
STOCH
47.50
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For ENVX, the sentiment is Negative. The current price of 4.94 is below the 20-day moving average (MA) of 5.43, below the 50-day MA of 6.52, and below the 200-day MA of 9.31, indicating a bearish trend. The MACD of -0.44 indicates Negative momentum. The RSI at 37.77 is Neutral, neither overbought nor oversold. The STOCH value of 47.50 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for ENVX.

Enovix Risk Analysis

Enovix disclosed 65 risk factors in its most recent earnings report. Enovix reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Enovix Peers Comparison

Overall Rating
UnderperformOutperform
Sector (63)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
63
Neutral
$10.79B15.437.44%2.01%2.89%-14.66%
60
Neutral
$758.10M-209.28-38.86%19.82%-7.14%
59
Neutral
$2.56B-22.34-49.74%234.14%42.67%
52
Neutral
$1.10B-10.09-0.23%45.98%44.14%
50
Neutral
$3.12B-1.40-110.00%2.53%-2.83%
48
Neutral
$705.85M-7.26-23.87%25.24%-12.96%
45
Neutral
$1.89B-3.0873.98%324.10%-214.91%
* Industrials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
ENVX
Enovix
5.07
-3.10
-37.94%
PLUG
Plug Power
2.24
0.54
31.76%
MVST
Microvast Holdings
2.31
0.86
59.31%
EOSE
Eos Energy Enterprises
5.56
1.40
33.65%
SLDP
Solid Power
3.20
2.05
178.26%
AMPX
Amprius Technologies Inc
18.69
16.46
738.12%

Enovix Corporate Events

Business Operations and StrategyStock BuybackFinancial Disclosures
Enovix Announces New Share Buyback and Record Revenue
Positive
Feb 25, 2026

On February 25, 2026, Enovix’s board authorized a new share repurchase plan for up to $75 million of common stock, supplementing its July 2025 program that had about $1.6 million of remaining capacity as of December 28, 2025 and runs through the end of 2026. The new plan, which has no expiration and can be started or halted at any time, underscores the company’s balance-sheet flexibility and could support the stock as it advances toward commercialization.

Also on February 25, 2026, Enovix reported record fourth-quarter 2025 revenue of $11.3 million and full-year 2025 revenue of $31.8 million, a 38% year-on-year increase driven mainly by defense and industrial shipments. Gross margins improved, cash burn narrowed versus 2024 and year-end liquidity stood at about $621 million, giving the company runway to complete smartphone qualification and scale production at its Fab2 facility in Malaysia.

Management said fourth-quarter evaluation samples for a lead smartphone customer met energy density, fast-charging and safety requirements, while cycle-life performance moved closer to qualification thresholds under updated silicon-specific protocols. Enovix highlighted smart eyewear as a potential early commercialization avenue, noting its AI-1 platform already meets key technical needs and that it has begun receiving initial production demand as customers move toward product launches.

During 2025, the company consolidated global manufacturing under new leadership, added seasoned high-volume manufacturing talent and reported steady gains in yield and throughput at Fab2, where laser dicing remains the main bottleneck. By resolving this constraint and leveraging newly obtained China Compulsory Certification and Underwriters Laboratories approvals for AI-1 smart eyewear batteries, Enovix aims to support higher-volume programs and strengthen its position in next-generation mobile and AI-centric devices.

The most recent analyst rating on (ENVX) stock is a Hold with a $10.00 price target. To see the full list of analyst forecasts on Enovix stock, see the ENVX Stock Forecast page.

Business Operations and StrategyExecutive/Board ChangesFinancial Disclosures
Enovix realigns leadership to support mass battery production
Positive
Jan 20, 2026

On January 19, 2026, Enovix announced that Chief Operating Officer Ajay Marathe will retire effective February 17, 2026, a move the company said was not related to any disagreement over its operations, policies, or practices. In a broader leadership realignment disclosed in a January 20, 2026 release, Enovix is shifting its operations organization to support the start of mass production of its batteries, expanding the role of Senior Vice President Kihong “KH” Park to lead global manufacturing operations and elevating Advanced Manufacturing Engineering to report directly to the CEO. The company has hired Ed Casey as Vice President, Operations to lead AME and added Sanghyuck Park as Senior Director, AME, both seasoned manufacturing executives with extensive experience scaling complex, high-volume production in Asia, Europe, and North America. Enovix credited its Korea operations under KH Park with strengthening regional performance and supporting approximately 38% preliminary, unaudited revenue growth in 2025, and it is positioning this new leadership structure to accelerate a disciplined, repeatable ramp as it transitions from qualification to sustained high-volume production, particularly at its Fab2 facility in Malaysia.

The most recent analyst rating on (ENVX) stock is a Buy with a $21.00 price target. To see the full list of analyst forecasts on Enovix stock, see the ENVX Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Feb 26, 2026